Complete response by patients with advanced hepatocellular carcinoma after combination immune/targeted therapy and transarterial chemoembolization: two case reports and literature review

BACKGROUND: Effective treatment for patients with advanced unresectable hepatocellular carcinoma (HCC) is severely lacking. The most common clinical treatments include a combination of immunotherapy, molecular targeted agents, and transarterial chemoembolization (TACE). The combinations of therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Nong, Xiang, Zhang, Yu-Mei, Liang, Jing-Chang, Xie, Jin-Long, Zhang, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459652/
https://www.ncbi.nlm.nih.gov/pubmed/36093545
http://dx.doi.org/10.21037/tcr-21-2691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459652/
https://www.ncbi.nlm.nih.gov/pubmed/36093545
http://dx.doi.org/10.21037/tcr-21-2691

Ejemplares similares